INCR
INCR
NASDAQ · Pharmaceuticals

Intercure Ltd

$0.96
+0.03 (+3.32%)
As of Aug 8, 2:10 AM ET ·
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Buy 6 86%
Hold 1 14%
Sell 0 0%
Price Target
Analyst Price Target +4,078.9% upside
Low Target $34.56
Average Target $39.95
High Target $63.39
Current Price $0.96
Current
$0.96
Target
$39.95
$34.56 $39.95 avg $63.39
Scenario Analysis
Bear Case
$34.56
3,515.1%
Low target
Base Case
$39.95
+4,078.9%
Avg target
Bull Case
$63.39
+6,530.8%
High target
Risk/Reward
1.9x
Balanced
Price in Context
52-Week High
$605.00
-99.8% from high
52-Week Low
$225.30
+-99.6% from low
Target vs 52W High
$39.95
-93.4% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 38 79% $1,330.33 +12.2%
RDY
Dr. Reddy's Laboratories
Sell 44 52% +0.0%
JNJ
Johnson & Johnson
Buy 31 68% $299.55 +15.5%
MRK
Merck & Co. Inc.
Buy 36 69% $159.27 +23.9%
PFE
Pfizer Inc.
Hold 36 42% $33.90 +26.7%
BMY
Bristol-Myers Squibb Co
Hold 35 40% $174.50 +169.6%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -36.1%
ZTS
Zoetis Inc
Hold 24 54% $209.87 +188.8%